{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:34:26Z","timestamp":1767339266825},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,4,20]],"date-time":"2013-04-20T00:00:00Z","timestamp":1366416000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s40266-013-0079-7","type":"journal-article","created":{"date-parts":[[2013,4,19]],"date-time":"2013-04-19T11:22:19Z","timestamp":1366370539000},"page":"503-512","source":"Crossref","is-referenced-by-count":16,"title":["Therapeutic Management of Primary Immunodeficiency in Older Patients"],"prefix":"10.1007","volume":"30","author":[{"name":"for the ESID Registry Working Party","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha","family":"Verma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Thaventhiran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Gathmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Thaventhiran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bodo","family":"Grimbacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,20]]},"reference":[{"issue":"6","key":"79_CR1","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jaci.2009.10.013","volume":"124","author":"LD Notarangelo","year":"2009","unstructured":"Notarangelo LD, Fischer A, Geha RS, Casanova JL, Chapel H, Conley ME, et al. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol. 2009;124(6):1161\u201378.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"79_CR2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/bies.201100093","volume":"33","author":"WA McEwan","year":"2011","unstructured":"McEwan WA, Mallery DL, Rhodes DA, Trowsdale J, James LC. Intracellular antibody-mediated immunity and the role of TRIM21. BioEssays. 2011;33(11):803\u20139. doi: 10.1002\/bies.201100093 . (Epub 2011 Aug 29).","journal-title":"BioEssays"},{"issue":"1 Suppl 1","key":"79_CR3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bbmt.2007.10.017","volume":"14","author":"MJ Cowan","year":"2008","unstructured":"Cowan MJ, Neven B, Cavazanna-Calvo M, Fischer A, Puck J. Hematopoietic stem cell transplantation for severe combined immunodeficiency diseases. Biol Blood Marrow Transpl. 2008;14(1 Suppl 1):73\u20135.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"79_CR4","first-page":"31","volume":"86","author":"RA Hermaszewski","year":"1993","unstructured":"Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med. 1993;86(1):31\u201342.","journal-title":"Q J Med"},{"issue":"1","key":"79_CR5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","volume":"92","author":"C Cunningham-Rundles","year":"1999","unstructured":"Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92(1):34\u201348.","journal-title":"Clin Immunol"},{"issue":"4","key":"79_CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.md.0000229482.27398.ad","volume":"85","author":"JA Winkelstein","year":"2006","unstructured":"Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine. 2006;85(4):193\u2013202.","journal-title":"Medicine"},{"issue":"6","key":"79_CR7","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.9.6.722","volume":"9","author":"OC Bruton","year":"1952","unstructured":"Bruton OC. Agammaglobulinemia. Pediatrics. 1952;9(6):722\u20138.","journal-title":"Pediatrics"},{"issue":"5","key":"79_CR8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/BF03401645","volume":"2","author":"SJ Kornfeld","year":"1996","unstructured":"Kornfeld SJ, Haire RN, Strong SJ, Tang H, Sung SS, Fu SM, et al. A novel mutation (Cys145\u2013>Stop) in Bruton\u2019s tyrosine kinase is associated with newly diagnosed X-linked agammaglobulinemia in a 51-year-old male. Molecular Med. 1996;2(5):619\u201323.","journal-title":"Molecular Med"},{"issue":"3","key":"79_CR9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/clim.2002.5241","volume":"104","author":"A Plebani","year":"2002","unstructured":"Plebani A, Soresina A, Rondelli R, Amato GM, Azzari C, Cardinale F, et al. Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. Clin Immunol. 2002;104(3):221\u201330.","journal-title":"Clin Immunol"},{"issue":"3","key":"79_CR10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.gde.2007.04.002","volume":"17","author":"AA Schaffer","year":"2007","unstructured":"Schaffer AA, Salzer U, Hammarstrom L, Grimbacher B. Deconstructing common variable immunodeficiency by genetic analysis. Current Opin Genet Dev. 2007;17(3):201\u201312.","journal-title":"Current Opin Genet Dev"},{"issue":"4","key":"79_CR11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10238-004-0027-2","volume":"3","author":"M Renzo Di","year":"2004","unstructured":"Di Renzo M, Pasqui AL, Auteri A. Common variable immunodeficiency: a review. Clin Exp Med. 2004;3(4):211\u20137.","journal-title":"Clin Exp Med"},{"issue":"2","key":"79_CR12","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2249.2006.03292.x","volume":"147","author":"AM Eades-Perner","year":"2007","unstructured":"Eades-Perner AM, Gathmann B, Knerr V, Guzman D, Veit D, Kindle G, et al. The European internet-based patient and research database for primary immunodeficiencies: results 2004\u201306. Clin Exp Immunol. 2007;147(2):306\u201312.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"79_CR13","first-page":"13","volume":"14","author":"W Santis De","year":"2006","unstructured":"De Santis W, Esposito A, Conti V, Fantauzzi A, Guerra A, Mezzaroma I, et al. Health care and infective aspects in patients affected by common variable immunodeficiency assisted in the Lazio Regional Authority Reference Centre for Primary Immunodeficiencies. Infez Med. 2006;14(1):13\u201323.","journal-title":"Infez Med"},{"issue":"3","key":"79_CR14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/clim.1999.4799","volume":"93","author":"ME Conley","year":"1999","unstructured":"Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93(3):190\u20137.","journal-title":"Clin Immunol"},{"issue":"5 Suppl 1","key":"79_CR15","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1081-1206(10)61142-8","volume":"94","author":"FA Bonilla","year":"2005","unstructured":"Bonilla FA, Bernstein IL, Khan DA, Ballas ZK, Chinen J, Frank MM, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol. 2005;94(5 Suppl 1):S1\u201363.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"79_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2011.04384.x","volume":"165","author":"F Dhalla","year":"2011","unstructured":"Dhalla F, da Silva SP, Lucas M, Travis S, Chapel H. Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol. 2011;165(1):1\u20137. doi: 10.1111\/j.1365-2249.2011.04384.x . (Epub 2011 Apr 6).","journal-title":"Clin Exp Immunol"},{"key":"79_CR17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1053\/j.gastro.2007.06.026","volume":"133","author":"P Correa","year":"2007","unstructured":"Correa P, Houghton JM. Carcinogenesis of Helicobacter pylori. Gastroenterology. 2007;133:659\u201372.","journal-title":"Gastroenterology"},{"issue":"1","key":"79_CR18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/gut.45.1.77","volume":"45","author":"A Zullo","year":"1999","unstructured":"Zullo A, Romiti A, Rinaldi V, Vecchione A, Tomao S, Aiuti F, Frati L, Luzi G. Gastric pathology in patients with common variable immunodeficiency. Gut. 1999;45(1):77\u201381.","journal-title":"Gut"},{"issue":"3","key":"79_CR19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ajh.10050","volume":"69","author":"C Cunnigham-Rundles","year":"2002","unstructured":"Cunnigham-Rundles C, Cooper DL, Duffy TP, Strauchen J. Lymphomas of mucosal associated lymphoid tissue in common variable immunodeficiency. Am J Hematol. 2002;69(3):171\u20138.","journal-title":"Am J Hematol"},{"issue":"2","key":"79_CR20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/10428190500285285","volume":"47","author":"A Aghamohammadi","year":"2006","unstructured":"Aghamohammadi A, Parvaneh N, Tirgari F, Mahjoob F, Movahedi M, Gharagozlou M, Mansouri M, Kouhi A, Rezaei N, Webster D. Lymphoma of mucosa-associated lymphoid tissue in common variable immunodeficiency. Leuk Lymphoma. 2006;47(2):343\u20136. (Review).","journal-title":"Leuk Lymphoma"},{"issue":"9637","key":"79_CR21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(08)61199-X","volume":"372","author":"MA Park","year":"2008","unstructured":"Park MA, Li JT, Hagan JB, Maddox DE, Abraham RS. Common variable immunodeficiency: a new look at an old disease. Lancet. 2008;372(9637):489\u2013502.","journal-title":"Lancet"},{"issue":"3","key":"79_CR22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2249.2002.02004.x","volume":"130","author":"L Mellemkjaer","year":"2002","unstructured":"Mellemkjaer L, Hammarstrom L, Andersen V, Yuen J, Heilmann C, Barington T, et al. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol. 2002;130(3):495\u2013500.","journal-title":"Clin Exp Immunol"},{"issue":"6A","key":"79_CR23","first-page":"85","volume":"14","author":"BD Spector","year":"1978","unstructured":"Spector BD, Perry GS, 3rd, Gajl-Peczalska KJ, Coccia P, Nesbit ME, Kersey JH. Malignancy in children with and without genetically-determined immunodeficiencies. Birth Defects Orig Artic Ser. 1978;14(6A):85\u20139.","journal-title":"Birth Defects Orig Artic Ser"},{"issue":"5","key":"79_CR24","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0091-6749(99)70085-0","volume":"104","author":"L Kainulainen","year":"1999","unstructured":"Kainulainen L, Varpula M, Liippo K, Svedstrom E, Nikoskelainen J, Ruuskanen O. Pulmonary abnormalities in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol. 1999;104(5):1031\u20136.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"79_CR25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1148\/radiol.2511081296","volume":"251","author":"A Sodickson","year":"2009","unstructured":"Sodickson A, Baeyens PF, Andriole KP, Prevedello LM, Nawfel RD, Hanson R, Khorasani R. Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. Radiology. 2009;251(1):175\u201384.","journal-title":"Radiology"},{"key":"79_CR26","doi-asserted-by":"crossref","unstructured":"Yong PF, Tarzi M, Chua I, Grimbacher B, Chee R. Common variable immunodeficiency: an update on etiology and management. Immunol Allergy Clin N Am. 2008;28(2):367\u201386, ix-x.","DOI":"10.1016\/j.iac.2008.01.001"},{"issue":"3","key":"79_CR27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10875-007-9075-1","volume":"27","author":"I Quinti","year":"2007","unstructured":"Quinti I, Soresina A, Spadaro G, Martino S, Donnanno S, Agostini C, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol. 2007;27(3):308\u201316.","journal-title":"J Clin Immunol"},{"issue":"1","key":"79_CR28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaut.2005.04.006","volume":"25","author":"J Wang","year":"2005","unstructured":"Wang J, Cunningham-Rundles C. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun. 2005;25(1):57\u201362.","journal-title":"J Autoimmun"},{"key":"79_CR29","doi-asserted-by":"crossref","unstructured":"Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, Vlkova M, Hernandez M, Detkova D, Bos PR, Poerksen G, von Bernuth H, Baumann U, Goldacker S, Gutenberger S, Schlesier M, Bergeron-van der Cruyssen F, Le Garff M, Debr\u00e9 P, Jacobs R, Jones J, Bateman E, Litzman J, van Hagen PM, Plebani A, Schmidt RE, Thon V, Quinti I, Espanol T, Webster AD, Chapel H, Vihinen M, Oksenhendler E, Peter HH, Warnatz K. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 2008;111(1):77\u201385 (Epub 2007 Sep 26).","DOI":"10.1182\/blood-2007-06-091744"},{"issue":"6","key":"79_CR30","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jbspin.2004.07.012","volume":"72","author":"C Sordet","year":"2005","unstructured":"Sordet C, Cantagrel A, Schaeverbeke T, Sibilia J. Bone and joint disease associated with primary immune deficiencies. Joint Bone Spine. 2005;72(6):503\u201314.","journal-title":"Joint Bone Spine"},{"issue":"1","key":"79_CR31","first-page":"25","volume":"22","author":"LJ Wang","year":"2004","unstructured":"Wang LJ, Yang YH, Lin YT, Chiang BL. Immunological and clinical features of pediatric patients with primary hypogammaglobulinemia in Taiwan. Asian Pac J Allergy Immunol. 2004;22(1):25\u201331.","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"3","key":"79_CR32","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.clim.2010.01.006","volume":"135","author":"T Kelesidis","year":"2010","unstructured":"Kelesidis T, Yang O. Good\u2019s syndrome remains a mystery after 55\u00a0years: a systematic review of the scientific evidence. Clin Immunol. 2010;135(3):347\u201363.","journal-title":"Clin Immunol"},{"key":"79_CR33","doi-asserted-by":"crossref","unstructured":"Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies. Clin Exp Immunol. 1999;118(Suppl 1):1\u201328.","DOI":"10.1046\/j.1365-2249.1999.00109.x"},{"issue":"Suppl 2","key":"79_CR34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2249.2011.04387.x","volume":"164","author":"SV Kaveri","year":"2011","unstructured":"Kaveri SV, Maddur MS, Hegde P, Lacroix-Desmazes S, Bayry J. Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy. Clin Exp Immunol. 2011;164(Suppl 2):2\u20135.","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"79_CR35","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.intimp.2004.02.011","volume":"4","author":"J Gracia de","year":"2004","unstructured":"de Gracia J, Vendrell M, Alvarez A, Pallisa E, Rodrigo MJ, de la Rosa D, et al. Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency. Int Immunopharmacol. 2004;4(6):745\u201353.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"79_CR36","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1023\/A:1006678312925","volume":"20","author":"HM Chapel","year":"2000","unstructured":"Chapel HM, Spickett GP, Ericson D, Engl W, Eibl MM, Bjorkander J. The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy. J Clin Immunol. 2000;20(2):94\u2013100.","journal-title":"J Clin Immunol"},{"issue":"5","key":"79_CR37","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3810\/pgm.2011.09.2474","volume":"123","author":"MR Stein","year":"2011","unstructured":"Stein MR, Koterba A, Rodden L, Berger M. Safety and efficacy of home-based subcutaneous immunoglobulin G in elderly patients with primary immunodeficiency diseases. Postgrad Med. 2011;123(5):186\u201393.","journal-title":"Postgrad Med"},{"issue":"2","key":"79_CR38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1081-1206(10)60197-4","volume":"101","author":"ML Moore","year":"2008","unstructured":"Moore ML, Quinn JM. Subcutaneous immunoglobulin replacement therapy for primary antibody deficiency: advancements into the 21st century. Ann Allergy Asthma Immunol. 2008;101(2):114\u201321. (Quiz 22\u20133, 78).","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"79_CR39","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/MOH.0b013e328338f69e","volume":"17","author":"PM Wood","year":"2010","unstructured":"Wood PM. Primary antibody deficiency syndromes. Current Opin Hematol. 2010;17(4):356\u201361.","journal-title":"Current Opin Hematol"},{"key":"79_CR40","doi-asserted-by":"crossref","unstructured":"Orange JS, Hossny EM, Weiler CR, Ballow M, Berger M, Bonilla FA, Buckley R, Chinen J, El-Gamal Y, Mazer BD, Nelson RP Jr, Patel DD, Secord E, Sorensen RU, Wasserman RL, Cunningham-Rundles C, Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol. 2006;117(4 Suppl):S525\u201353.","DOI":"10.1016\/j.jaci.2006.01.015"},{"issue":"4","key":"79_CR41","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.intimp.2005.11.015","volume":"6","author":"DJ Hamrock","year":"2006","unstructured":"Hamrock DJ. Adverse events associated with intravenous immunoglobulin therapy. Int Immunopharmacol. 2006;6(4):535\u201342.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"79_CR42","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1517\/14740338.2010.484419","volume":"9","author":"JB Caress","year":"2006","unstructured":"Caress JB, Kennedy BL, Eickman KD. Safety of intravenous immunoglobulin treatment. Expert Opin Drug Safety. 2006;9(6):971\u20139.","journal-title":"Expert Opin Drug Safety"},{"issue":"9","key":"79_CR43","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2165\/11592740-000000000-00000","volume":"28","author":"MJ Cheng","year":"2011","unstructured":"Cheng MJ, Christmas C. Special considerations with the use of intravenous immunoglobulin in older persons. Drugs Aging. 2011;28(9):729\u201336.","journal-title":"Drugs Aging"},{"issue":"5","key":"79_CR44","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.mbc.0000172694.85233.a8","volume":"16","author":"D Paran","year":"2005","unstructured":"Paran D, Herishanu Y, Elkayam O, Shopin L, Ben-Ami R. Venous and arterial thrombosis following administration of intravenous immunoglobulins. Blood Coagul Fibrinolysis. 2005;16(5):313\u20138.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"79_CR45","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00415-009-0969-0","volume":"256","author":"JB Caress","year":"2009","unstructured":"Caress JB, Hobson-Webb L, Passmore LV, Finkbiner AP, Cartwright MS. Case-control study of thromboembolic events associated with IV immunoglobulin. J Neurol. 2009;256(3):339\u201342.","journal-title":"J Neurol"},{"issue":"Suppl 2","key":"79_CR46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcf.2005.05.018","volume":"4","author":"N Hoiby","year":"2005","unstructured":"Hoiby N, Frederiksen B, Pressler T. Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros. 2005;4(Suppl 2):49\u201354.","journal-title":"J Cyst Fibros"},{"issue":"10","key":"79_CR47","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJMoa050078","volume":"353","author":"M Cullen","year":"2005","unstructured":"Cullen M, Steven N, Billingham L, Gaunt C, Hastings M, Simmonds P, et al. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med. 2005;353(10):988\u201398.","journal-title":"N Engl J Med"},{"key":"79_CR48","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1741-7015-9-32","volume":"9","author":"N Hoiby","year":"2011","unstructured":"Hoiby N. Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis. BMC Med. 2011;9:32.","journal-title":"BMC Med"},{"key":"79_CR49","doi-asserted-by":"crossref","unstructured":"Green H, Paul M, Vidal L, Leibovici L. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev. 2007(3):CD005590.","DOI":"10.1002\/14651858.CD005590.pub2"},{"key":"79_CR50","doi-asserted-by":"crossref","unstructured":"Lucas M, Lee M, Lortan J, Lopez-Granados E, Misbah S, Chapel H. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22\u00a0years. J Allergy Clin Immunol. 2010;125(6):1354\u201360.e4. (Epub 2010 May 14).","DOI":"10.1016\/j.jaci.2010.02.040"},{"issue":"2","key":"79_CR51","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1365-2141.2002.03269.x","volume":"116","author":"HJ Longhurst","year":"2002","unstructured":"Longhurst HJ, Taussig D, Haque T, Syndercombe-Court D, Cavenagh J, Edgar JD, et al. Non-myeloablative bone marrow transplantation in an adult with Wiskott\u2013Aldrich syndrome. Br J Haematol. 2002;116(2):497\u20139.","journal-title":"Br J Haematol"},{"key":"79_CR52","doi-asserted-by":"crossref","unstructured":"Rizzi M, Neumann C, Fielding AK, Marks R, Goldacker S, Thaventhiran J, et al. Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency. J Allergy Clin Immunol. 2011;128(6):1371\u20134.e2.","DOI":"10.1016\/j.jaci.2011.07.055"},{"issue":"11","key":"79_CR53","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nri2195","volume":"7","author":"L Marodi","year":"2007","unstructured":"Marodi L, Notarangelo LD. Immunological and genetic bases of new primary immunodeficiencies. Nat Rev. 2007;7(11):851\u201361.","journal-title":"Nat Rev"},{"key":"79_CR54","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/B978-0-12-385991-4.00002-7","volume":"111","author":"PF Yong","year":"2011","unstructured":"Yong PF, Thaventhiran JE, Grimbacher B. \u201cA rose is a rose is a rose,\u201d but CVID is not CVID common variable immune deficiency (CVID), what do we know in 2011? Adv Immunol. 2011;111:47\u2013107.","journal-title":"Adv Immunol"},{"issue":"4","key":"79_CR55","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1056\/NEJMoa1000164","volume":"363","author":"S Hacein-Bey-Abina","year":"2010","unstructured":"Hacein-Bey-Abina S, Hauer J, Lim A, Picard C, Wang GP, Berry CC, et al. Efficacy of gene therapy for X-linked severe combined immunodeficiency. N Engl J Med. 2010;363(4):355\u201364.","journal-title":"N Engl J Med"},{"key":"79_CR56","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1749-6632.2010.05834.x","volume":"1214","author":"A Alcais","year":"2010","unstructured":"Alcais A, Quintana-Murci L, Thaler DS, Schurr E, Abel L, Casanova JL. Life-threatening infectious diseases of childhood: single-gene inborn errors of immunity? Ann N Y Acad Sci. 2010;1214:18\u201333.","journal-title":"Ann N Y Acad Sci"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-013-0079-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-013-0079-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-013-0079-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T11:59:44Z","timestamp":1644839984000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-013-0079-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,20]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["79"],"URL":"https:\/\/doi.org\/10.1007\/s40266-013-0079-7","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"type":"print","value":"1170-229X"},{"type":"electronic","value":"1179-1969"}],"subject":[],"published":{"date-parts":[[2013,4,20]]}}}